Sat Kartar Shopping IPO

Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company focused on delivering natural wellness solutions for therapeutic and lifestyle products, promoting a healthier lifestyle. The company offers holistic, natural remedies and lifestyle products based on traditional Ayurveda practices, serving individual consumers directly. It sells products through its own website, third-party e-commerce platforms, television marketing, and Google and Meta applications. Their Products: Specific Problem Led Niche Therapeutic Areas: The company targets specialized fields within the medical and healthcare domain that focus on addressing specific health issues or challenges such as addiction, personal care, wellness, and others. Products are Addiction Killer,Liv Muztang etc. Lifestyle Led Curative Areas:The company also targets specialized fields within healthcare and medicine that focus on addressing health issues related to individuals' lifestyles, such as diabetes, joint pain relief, piles, and other health concerns. The company is diversifying its product portfolio to include products related to various health issues such as slimming, hair care, gut health, PCOD (Poly Cystic Ovary Disease), and mental wellness. As on November 30, 2024, the company has a total of 1,122 employees operating under various department. Competitive Strength: Emerging brand with PAN India presence Asset light Business Model Strong Digital Media presence. Anonymity of Customers In house research and development Clinical Trials Well Structured Logistics process

The objects of the Issue are: - To meet the expenses of Unidentified Acquisition (In India or Abroad) To meet the expenses, Marketing and Advertisement To meet the Capital Expenditure To meet the expenditure on Investment in Technology To meet out the General Corporate Purposes; and To meet out the Issue Expenses.

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App